返回ChemicalBook首页>CAS数据库列表>130-01-8

130-01-8

中文名称 千里光宁
英文名称 SENECIONINE
CAS 130-01-8
分子式 C18H25NO5
分子量 335.39
MOL 文件 130-01-8.mol
更新日期 2024/04/19 16:13:42
130-01-8 结构式 130-01-8 结构式

基本信息

中文别名
千里光宁
千里光宁碱
千里光寧鹼
千里光碱/ 千里光宁
英文别名
qlgn
Aureine
SENECIONIN
Sencionine
SENECIONINE
Senecionine/Aureine
16-dione,12-hydroxy-senecionan-1
12-Hydroxysenecionan-11,16-dione
Senecionan-11,16-dione, 12-hydroxy-
(15cis)-12-Hydroxysenecionan-11,16-dione
所属类别
天然产物:生物碱

物理化学性质

外观性状白色结晶粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于菊三七,千里光Senecio scandens Buch.-Ham. ex D. Don,欧洲千里光 Senecio vulgaris L.全草 菊叶千里光 S.chrysanthemoides DC.根 牙克贝千里光 S.jacobaea L.。
熔点236 °C(lit.)
比旋光度D25 -55.1° (c = 0.034 in chloroform)
沸点472.03°C (rough estimate)
密度1.266 g/cm3
折射率1.5100 (estimate)
储存条件−20°C
溶解度DMF: 5 mg/ml; DMSO: 2 mg/ml; Ethanol: 1 mg/ml; PBS (pH 7.2): 0.1 mg/ml
酸度系数(pKa)12.81±0.40(Predicted)
形态neat
旋光性 (optical activity)[α]25/D 55.1°, c = 0.034% in chloroform
BRN8162955
InChIKeyHKODIGSRFALUTA-JTLQZVBZSA-N
LogP0.880 (est)
EPA化学物质信息Senecionine (130-01-8)

安全数据

危险性符号(GHS)
GHS06
警示词危险
危险性描述H300+H310+H330
危险品标志T
危险类别码25
安全说明45
危险品运输编号UN 2811 6.1/PG 3
WGK Germany3
RTECS号VT5710000
危险等级6.1(a)
包装类别II
毒性LD50 i.v. in mice: 64.12 ±2.24 mg/kg (Harris)

应用领域

用途1
用于含量测定/鉴定/药理实验等。
用途2
千里光宁具有凝血止血、消炎和抗病毒的作用。
千里光宁价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/01/25HY-N2560千里光宁
Senecionine
130-01-81mg860元
2024/01/25HY-N2560千里光宁
Senecionine
130-01-85mg2600元
2024/01/25HY-N2560千里光宁
Senecionine
130-01-810mg4100元

常见问题列表

生物活性
Senecionine (Senecionan-11,16-dione, 12-hydroxy-) 是一种从 Senecio vulgaris 中分离出来的吡咯里西啶生物碱。 Senecionine对动物和人类有毒。
体外研究

Pyrrolizidine alkaloids (PAs) are considered to be one of the most hepatotoxic groups of compounds of plant origin and are present in about 3% of the world's flowering plants. Most PAs represent a considerable health hazard to both livestock and humans through the consumption of plants and PA-contaminated products such as milk, honey, herbal teas, and medicines.

体内研究

Upon intravenous administration and oral administration of Senecionine and Adonifoline, significant differences in pharmacokinetics were observed, with the Senecionine and Adonifoline being absorbed fast with lower bioavailability and being quickly metabolized to PA N-oxides and hydroxylation products of PAs or their N-oxides. Senecionine fails to stimulate epoxide hydrase, it diminishs the activity of glutathione-s-transferase, aminopyrine demethylase and AHH. Twice-weekly injections of a third constituent, senecionine, beginning on Day 12 or later, results in premature deliveries in three of seven rats, and the pups from all litters are stillborn or die shortly after birth.

"130-01-8" 相关产品信息
105-16-8 3058-01-3 2426-54-2